Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. - Smith MR; McGovern FJ; Zietman AL; Fallon MA; Hayden DL; Schoenfeld DA; Kantoff PW; Finkelstein JS (New England Journal of Medicine, 2001)